Showing results (141-150 of 161) with videos related to

Sort By:
Pageof 17
Journal of Chemical Information and Modeling|September 16, 2020
Alchemical Binding Free Energy Calculations in AMBER20: Advances and Best Practices for Drug DiscoveryTai-Sung Lee, Bryce K Allen, Timothy J Giese, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2025
SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II TrialConstanza Vargas, Joe Carrello, Mathias Bressel, et al.
International Journal of Radiation Oncology, Biology, Physics|June 7, 2021
Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) - A Trans-Tasman Radiation Oncology Group StudyDanny Rischin, Madeleine King, Lizbeth Kenny, et al.
Blood|December 8, 2009
Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemiaAldo M Roccaro, Antonio Sacco, Emanuel N Husu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 24, 2022
Remediating Desmoplasia with EGFR-Targeted Photoactivable Multi-Inhibitor Liposomes Doubles Overall Survival in Pancreatic CancerGirgis Obaid, Shazia Bano, Hanna Thomsen, et al.
Nature|March 23, 2010
Bone progenitor dysfunction induces myelodysplasia and secondary leukaemiaMarc H G P Raaijmakers, Siddhartha Mukherjee, Shangqin Guo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 19, 2005
Induction of CYP1A in the beagle dog by an inhibitor of kinase insert domain-containing receptor: differential effects in vitro and in vivo on mRNA and functional activityChristopher R Gibson, Charles Lin, Rominder Singh, et al.
Nature Communications|December 7, 2018
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancerJingyi Liu, Zhibing Duan, Weijie Guo, et al.
Pageof 17